You are here

Resource Center

Press Release
PARSIPPANY, N.J. — April 07, 2014 — Delta Dental of New Jersey has invested $5 million in C3 Jian, Inc. to support the company’s development of an antimicrobial drug that targets the bacteria responsible for tooth decay. It is one of several Delta Dental member companies and affiliated organizations that have made substantial investments in C3 Jian.
Laird Harrison
An experimental nasal spray can provide maxillary dental anesthesia equivalent to a lidocaine injection, new studies show. The phase 2 trial of the spray in 45 adults was published online May 20 and in a July clinical supplement to the Journal of Dental Research...
Authors: Albert Guay, D.M.D; Matthew Warren, M.A.; Rebecca Starkel, M.A.; Marko Vujicic, Ph.D.